MARINUS PHARMACEUTICALS ($MRNS) is expected to release its quarterly earnings data on Tuesday, March 11th after market close, per Finnhub. Analysts are expecting revenue of $10,802,310 and earnings of -$0.34 per share.
You can see Quiver Quantitative's $MRNS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MARINUS PHARMACEUTICALS Insider Trading Activity
MARINUS PHARMACEUTICALS insiders have traded $MRNS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MRNS stock by insiders over the last 6 months:
- MARVIN JOHNSON sold 1,610 shares for an estimated $869
- ELAN EZICKSON sold 1,600 shares for an estimated $864
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MARINUS PHARMACEUTICALS Hedge Fund Activity
We have seen 22 institutional investors add shares of MARINUS PHARMACEUTICALS stock to their portfolio, and 77 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SUVRETTA CAPITAL MANAGEMENT, LLC removed 5,073,913 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,715,050
- FRANKLIN RESOURCES INC removed 4,713,014 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,521,933
- SOFINNOVA INVESTMENTS, INC. removed 4,386,177 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,347,043
- BERYL CAPITAL MANAGEMENT LLC added 4,227,460 shares (+inf%) to their portfolio in Q4 2024, for an estimated $2,262,113
- MORGAN STANLEY added 3,134,161 shares (+1898.7%) to their portfolio in Q4 2024, for an estimated $1,677,089
- TANG CAPITAL MANAGEMENT LLC removed 3,058,055 shares (-65.1%) from their portfolio in Q4 2024, for an estimated $1,636,365
- ODDO BHF ASSET MANAGEMENT SAS added 2,700,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,444,770
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
